Side-by-side comparison of AI visibility scores, market position, and capabilities
Jacksonville Class I eastern US railroad (NASDAQ: CSX) ~$14.5B 2024 revenue; PSR operating model, new CEO Steve Angel (Sept 2025, ex-Linde), 20,000 route miles competing with Norfolk Southern for eastern freight.
CSX Corporation is a Jacksonville, Florida-based Class I freight railroad — publicly traded on NASDAQ (NASDAQ: CSX) as an S&P 500 Industrials component — operating approximately 20,000 route miles across 26 states in the eastern United States and two Canadian provinces, connecting industrial facilities, ports, agricultural markets, intermodal terminals, and power plants through approximately 22,000 employees. CSX transports merchandise freight (chemicals, automotive, agricultural products, metals, food), intermodal containers and trailers, and coal (utility coal to power plants and export coal to terminals) across the densest rail network in the eastern US, including critical connections to the Port of Baltimore, Port of Savannah, and Port of Norfolk. In fiscal year 2024, CSX reported revenue of approximately $14.5 billion, with the Precision Scheduled Railroading (PSR) operating model maintaining operating ratio efficiency while managing volume volatility from coal headwinds and intermodal competition. A defining leadership development is the September 28, 2025 appointment of Steve Angel as President and CEO, succeeding Joe Hinrichs — Angel brings two decades of operational experience from Linde plc (where he served as CEO from 2018 to 2022 and oversaw the $90B Linde-Praxair merger) and 22 years at General Electric working directly with locomotive and rail operations, bringing a manufacturing and industrial operations discipline to CSX's continued operational improvement agenda.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.